These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38232626)

  • 1. Generation of a patient-specific iPSC cell line with cardiac arrhythmias and dilated cardiomyopathy (CBRCULi016-A), an isogenic control (CBRCULi016-A-1), and a paternal control (CBRCULi017-A).
    Djemai M; Jauvin D; Poulin H; Chapotte-Baldacci CA; Chahine M
    Stem Cell Res; 2024 Mar; 75():103308. PubMed ID: 38232626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing.
    Barndt RJ; Ma N; Tang Y; Haugh MP; Alamri LS; Chan SY; Wu H
    Stem Cell Res; 2021 Oct; 56():102544. PubMed ID: 34583280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a pluripotent stem cell line (UMGi270-A) and a corresponding CRISPR/Cas9 modified isogenic control (UMGi270-A-1) from a patient with sudden onset dilated cardiomyopathy harboring a FLNC p.R2187P mutation.
    Maurer W; Rebs S; Köhne S; Eberl H; Wollnik B; Zibat A; Streckfuss-Bömeke K
    Stem Cell Res; 2024 Jun; 77():103409. PubMed ID: 38583294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients.
    Caudal A; Mondejar-Parreño G; Vera CD; Williams DR; Shenoy SP; Liang D; Wu JC
    Stem Cell Res; 2022 Aug; 63():102855. PubMed ID: 35853412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of two iPSC lines from dilated cardiomyopathy patients with pathogenic variants in the SCN5A gene.
    Dexheimer R; Manhas A; Wu D; Tripathi D; Yu Chan S; Li J; Yu R; Sayed N; Wu JC; Sallam K
    Stem Cell Res; 2024 Oct; 80():103498. PubMed ID: 39067410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying heterozygous FLNC mutations.
    Kojic A; Kim H; Guevara JV; Ravada S; Sallam K; Wu JC
    Stem Cell Res; 2022 Oct; 64():102928. PubMed ID: 36194907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a heterozygous FLNC mutation-carrying human iPSC line, USFi002-A, for modeling dilated cardiomyopathy.
    Argenziano MA; Burgos Angulo M; Najari Beidokhti M; Yang J; Bertalovitz AC; McDonald TV
    Stem Cell Res; 2021 May; 53():102394. PubMed ID: 34088019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating
    Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639
    [No Abstract]   [Full Text] [Related]  

  • 9. Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying TTN mutations.
    Zhang TT; Zhao SR; Alamana C; Shen M; Parikh V; Wheeler MT; Wu JC
    Stem Cell Res; 2022 Dec; 65():102941. PubMed ID: 36270069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a human iPSC (ZZUNEUi026-A) from a dilated cardiomyopathy patient carrying heterozygous Vinculin (c. 625A > T) mutant.
    Liu Y; Li X; Zhao X; Dong J; Zhang C; Lin T
    Stem Cell Res; 2022 Jul; 62():102812. PubMed ID: 35567849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of CRISPR-Cas9 edited human induced pluripotent stem cell line carrying FLNC exon skipping variant.
    Ader F; Duboscq-Bidot L; Marteau S; Hamlin M; Richard P; Fontaine V; Villard E
    Stem Cell Res; 2022 Jan; 58():102616. PubMed ID: 34883448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a hiPSC line ZZUNEUi017-A from a patient with dilated cardiomyopathy caused by mutation in TTN.
    Huang S; Fu W; Guo G; Tiana X; Zhao X; Dong J; Li X; Yang H
    Stem Cell Res; 2021 Apr; 52():102248. PubMed ID: 33610015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of two iPSC lines (FAMRCi006-A and FAMRCi006-B) from patient with dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy associated with genetic variant LMNAp.Arg527Pro.
    Perepelina K; Klauzen P; Khudiakov A; Zlotina A; Fomicheva Y; Rudenko D; Gordeev M; Sergushichev A; Malashicheva A; Kostareva A
    Stem Cell Res; 2020 Mar; 43():101714. PubMed ID: 32059175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients caused by heterozygous mutations in the HCN4 gene.
    Yildirim Z; Kojic A; Yan CD; Wu MA; Vagelos R; Wu JC
    Stem Cell Res; 2022 Dec; 65():102951. PubMed ID: 36332467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of CRISPR-Cas9 edited human induced pluripotent stem cell line carrying BAG3 V468M mutation in its BAG domain.
    Duboscq-Bidot L; Hoareau B; Ader F; Fontaine V; Villard E
    Stem Cell Res; 2024 Feb; 74():103294. PubMed ID: 38183888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a human induced pluripotent stem cell line from a patient with dilated cardiomyopathy.
    Ye L; Ni B; Wu H; Han X; Li H; Liu J; Hu S; Lei W
    Stem Cell Res; 2024 Aug; 78():103467. PubMed ID: 38861774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an iPSC cell line (USFi003-A) from a patient with dilated cardiomyopathy carrying a heterozygous mutation in LMNA (p.R541C).
    Yang J; Burgos Angulo M; Argenziano MA; Bertalovitz A; Najari Beidokhti M; McDonald TV
    Stem Cell Res; 2021 Jul; 54():102396. PubMed ID: 34029931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a human induced pluripotent stem cell line derived from a patient with dilated cardiomyopathy carrying LMNA nonsense mutation.
    Shimoda Y; Murakoshi N; Mori H; Xu D; Tajiri K; Hemmi Y; Sato I; Noguchi M; Nakamura Y; Hayashi Y; Ieda M
    Stem Cell Res; 2022 Jul; 62():102793. PubMed ID: 35500377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human induced pluripotent stem cell line YCMi007-A generated from a dilated cardiomyopathy patient with a heterozygous dominant c.613C > T (p. Arg205Trp) variant of the TNNT2 gene.
    Jeon SB; Kim H; Chun KH; Oh J; Kwon C; Choi HK; Kim S; Kim HP; Kim IC; Yoo JY; Park SW; Kang SM; Lee SH
    Stem Cell Res; 2023 Mar; 67():103048. PubMed ID: 36801602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of simultaneous reprogramming and gene correction to generate an osteogenesis imperfecta patient COL1A1 c. 3936 G>T iPSC line and an isogenic control iPSC line.
    Howden S; Hosseini Far H; Motazedian A; Elefanty AG; Stanley EG; Lamandé SR; Bateman JF
    Stem Cell Res; 2019 Jul; 38():101453. PubMed ID: 31082677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.